108 related articles for article (PubMed ID: 17064988)
41. Comparison of Serum CA72-4 and CEA Levels in Patient with Endoscopically Suspected Gastric Carcinoma.
Rehena Z; Ghosh CK; Afroz F; Alam MB; Ferdousi S; Mahmuduzzaman M; Sultana T; Ahmed AN
Mymensingh Med J; 2015 Jul; 24(3):542-9. PubMed ID: 26329953
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of the Clinical Significance of Serum Carcinoembryonic Antigen in Patients with Resectable Gastric Adenocarcinoma.
Dang Y; Ouyang X; Wang K; Zhang F; Huang Q
Arch Med Res; 2016 Apr; 47(3):196-9. PubMed ID: 27387021
[TBL] [Abstract][Full Text] [Related]
43. Receiver operating characteristic (ROC) curve analysis of the tumor markers CEA, CA 19-9 and CA 72-4 in gastric cancer.
Fernández-Fernández L; Tejero E; Tieso A; Rabadán L; Munoz M; Santos I
Int Surg; 1996; 81(4):400-2. PubMed ID: 9127805
[TBL] [Abstract][Full Text] [Related]
44. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
Tabata T; Takeshima N; Tanaka N; Hirai Y; Hasumi K
Tumour Biol; 2000; 21(6):375-80. PubMed ID: 11006578
[TBL] [Abstract][Full Text] [Related]
45. [Ca-19-9, carcinoembryonic antigen, and alpha-fetoprotein in the serum of nononcological patients and their clinical significance].
Skvortsov SV; Kushlinskiĭ NE; Kadagidze ZG; Kasumov ChM
Biull Eksp Biol Med; 1997 May; 123(5):566-9. PubMed ID: 9264714
[No Abstract] [Full Text] [Related]
46. Tumour markers in uraemia: carbohydrate antigen CA 72-4, carcinoembryonic antigen and carbohydrate antigen CA 19-9.
Fernández-Fernández L; Asensio M; Tejero E; Rabadán L; Lopez L
Ann Clin Biochem; 1996 Nov; 33 ( Pt 6)():563-4. PubMed ID: 8937591
[No Abstract] [Full Text] [Related]
47. Increased serum CA-15.3 levels in patients with megaloblastic anemia due to vitamin B12 deficiency.
Symeonidis A; Kouraklis-Symeonidis A; Apostolopoulos D; Arvanitopoulou E; Giannakoulas N; Vassilakos P; Zoumbos N
Oncology; 2004; 67(5-6):359-67. PubMed ID: 15713991
[TBL] [Abstract][Full Text] [Related]
48. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma.
Reiter W; Stieber P; Reuter C; Nagel D; Cramer C; Pahl H; Fateh-Moghadam A
Anticancer Res; 1997; 17(4B):2903-6. PubMed ID: 9329559
[TBL] [Abstract][Full Text] [Related]
50. Serum tumor markers after renal transplantation.
Oberbauer R; Banyai S; Schmidt A; Kornek G; Scheithauer W; Mayer G
Transplantation; 1996 Nov; 62(10):1506-9. PubMed ID: 8958280
[TBL] [Abstract][Full Text] [Related]
51. [The use of the carbohydrate antigen CA-19-9, the carcinoembryonic antigen and alpha fetoprotein in the diagnosis of pancreatic cancer].
Skvortsov SV; Kalinin AV; Lytsar' BN
Vestn Ross Akad Med Nauk; 1993; (4):47-9. PubMed ID: 7687486
[TBL] [Abstract][Full Text] [Related]
52. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
Spila A; Ferroni P; Cosimelli M; D'Alessandro R; Abbolito MR; Mariotti S; Aloe S; Carone MD; Graziano F; Tedesco M; Martini F; Mancini R; Stigliano V; Roselli M; Guadagni F
Anticancer Res; 2001; 21(2B):1263-70. PubMed ID: 11396197
[TBL] [Abstract][Full Text] [Related]
53. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
[TBL] [Abstract][Full Text] [Related]
54. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
Yang XQ; Chen C; Wang FB; Peng CW; Li Y
Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
[TBL] [Abstract][Full Text] [Related]
55. Tumor markers in patients with chronic renal failure.
Filella X; Cases A; Molina R; Jo J; Bedini JL; Revert L; Ballesta AM
Int J Biol Markers; 1990; 5(2):85-8. PubMed ID: 1704405
[TBL] [Abstract][Full Text] [Related]
56. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
57. Significance of combined tests of serum golgi glycoprotein 73 and other biomarkers in diagnosis of small primary hepatocellular carcinoma.
Zhao Y; Wang M; Cui C; Zhang L; Liao F; Li H; Wu X
Cancer Biomark; 2015; 15(5):677-83. PubMed ID: 26406957
[TBL] [Abstract][Full Text] [Related]
58. Influence of cardiopulmonary resuscitation on levels of tumour markers.
Berent R; Auer J; Porodko M; Lamm G; Weber T; Wimmer E; Seier J; Aspöck G; Eber B
Eur J Cancer Care (Engl); 2006 Jul; 15(3):252-6. PubMed ID: 16882121
[TBL] [Abstract][Full Text] [Related]
59. Measurement of tumor markers in chronic hemodialysis patients.
Tzitzikos G; Saridi M; Filippopoulou T; Makri A; Goulioti A; Stavropoulos T; Stamatiou K
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):50-3. PubMed ID: 20061692
[TBL] [Abstract][Full Text] [Related]
60. Tumour markers and screening for gastrointestinal cancer: a follow up study in Finland.
Hakama M; Stenman UH; Knekt P; Järvisalo J; Leino A; Hakulinen T; Maatela J; Aromaa A
J Med Screen; 1994 Jan; 1(1):60-4. PubMed ID: 8790487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]